EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy

Xueqiang Peng, Jianjun Fang, Chuyuan Lou, Liang Yang, Shaobo Shan, Zixian Wang, Yutong Chen, Hangyu Li, Xuexin Li

Acta Pharmaceutica Sinica B · 2024-08 · 14 (8) · 3432-3456

DOI: 10.1016/j.apsb.2024.05.010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2024-08. Verfasst von Xueqiang Peng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Fourth Affiliated Hospital, China Medical University, Shenyang 110032, China. Die Arbeit wurde bisher 107-mal zitiert (Crossref) und nennt 217 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Liaoning Province, Karolinska Institutet, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Blood–brain barrierCancerCancer immunotherapyDrug deliveryEngineered nanoparticlesNanomaterialNanomedicineTumor-barrier

Autor:innen und Institutionen

  • Department of General Surgery, The Fourth Affiliated Hospital, China Medical University, Shenyang 110032, China.
  • Department of Ophthalmology, Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an 710004, China.
  • Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 10050, China.
  • Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China.
  • Department of Pathology, Medical College, Jinan University, Guangzhou 510632, China.
  • Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm SE-17177, Sweden.

Förderung

  • Natural Science Foundation of Liaoning Province
  • Karolinska Institutet
  • China Postdoctoral Science Foundation

Zitieren

APA

Peng, X., Fang, J., Lou, C., Yang, L., Shan, S., Wang, Z., Chen, Y., Li, H., & Li, X. (2024). Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy. Acta Pharmaceutica Sinica B, 14(8), 3432-3456. https://doi.org/10.1016/j.apsb.2024.05.010

Vancouver

Peng X, Fang J, Lou C, Yang L, Shan S, Wang Z, et al. Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy. Acta Pharmaceutica Sinica B. 2024;14(8):3432-3456. doi:10.1016/j.apsb.2024.05.010

BibTeX
@article{Peng2024,
  author = {Peng, Xueqiang and Fang, Jianjun and Lou, Chuyuan and Yang, Liang and Shan, Shaobo and Wang, Zixian and Chen, Yutong and Li, Hangyu and Li, Xuexin},
  title = {Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2024},
  volume = {14},
  number = {8},
  pages = {3432--3456},
  doi = {10.1016/j.apsb.2024.05.010}
}
Kostenlos starten →